UPL Limited

Informe acción BSE:512070

Capitalización de mercado: ₹545.6b

UPL Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de UPL de 42% y 7.8% por año respectivamente. Se prevé que el BPA crezca en un 41.3% al año. Se espera que la rentabilidad financiera sea de 11.6% en 3 años.

Información clave

42.0%

Tasa de crecimiento de los beneficios

41.26%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals20.5%
Tasa de crecimiento de los ingresos7.8%
Rentabilidad financiera futura11.56%
Cobertura de analistas

Good

Última actualización30 Apr 2026

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Actualización del análisis • May 01

512070: Fair Pricing Will Depend On Execution Of Upcoming Restructuring And Treasury Plans

Analysts have trimmed their price target on UPL from ₹647.56 to ₹630.00, citing updated assumptions around revenue growth, profit margin, discount rate and future P/E that slightly adjust their valuation framework. What's in the News UPL has scheduled a Special or Extraordinary Shareholders Meeting on March 31, 2026, at 15:30 IST to consider and approve material related party transactions for sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).
Actualización del análisis • Apr 17

512070: Composite Scheme And Governance Steps Will Support Stronger Medium Term Outlook

Analysts have trimmed their price target on UPL slightly from about ₹820.53 to ₹811.50, reflecting updated assumptions around the discount rate, revenue growth, profit margin and future P/E multiple. What's in the News Board meeting on Feb 20, 2026 to consider a Composite Scheme of Arrangement among UPL Limited and multiple group entities under Sections 230 to 232 and 234 of the Companies Act, 2013, based on recommendations from the Audit Committee and the Committee of Independent Directors (company filing).
Actualización del análisis • Apr 03

512070: Upcoming Governance Decisions And Treasury Scheme Will Support A Stronger Outlook

Analysts have trimmed their price target on UPL from ₹975 to ₹947, citing updated assumptions on long term profit margins and P/E multiples, along with refreshed views on growth, discount rates and fair value. What's in the News UPL has called a Special or Extraordinary Shareholders Meeting for March 31, 2026, at 15:30 IST to seek approval for material related party transactions involving sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).
Actualización del análisis • Mar 19

512070: Fair Pricing Will Rely On Execution Of Upcoming Restructuring Steps

Analysts have nudged their price target on UPL slightly higher to about ₹648 from roughly ₹641, citing updated assumptions around revenue growth, profit margins, a modestly lower discount rate, and a small adjustment to the expected future P/E multiple. What's in the News UPL has scheduled a board meeting on Feb 02, 2026 at 12:45 Indian Standard Time to consider and approve unaudited consolidated and standalone financial results for the quarter and nine months ended Dec 31, 2025, along with limited review reports from the statutory auditors (Key Developments).
Actualización del análisis • Mar 05

512070: Composite Scheme Board Meeting Will Support Stronger Medium Term Outlook

Analysts have raised their price target on UPL by about ₹39 to ₹820, citing updated assumptions that reflect a slightly lower discount rate, a modest tweak to revenue growth and P/E expectations, and a higher projected profit margin. What's in the News Board meeting scheduled for Feb 20, 2026 at 14:30 IST to consider a Composite Scheme of Arrangement involving UPL and its subsidiaries UPL Sustainable Agri Solutions Limited, UPL Global Sustainable Agri Solutions Limited, and UPL Crop Protection Holdings Limited under Sections 230 to 232 and 234 of the Companies Act, 2013 (company filing).
Actualización del análisis • Feb 18

512070: Revised Margins And Lower P/E Will Likely Struggle To Support Pricing

Analysts have raised their fair value estimate for UPL from ₹600.67 to ₹641.03, citing updated views on the discount rate, revenue growth, profit margins and future P/E assumptions. What's in the News Board meeting scheduled for Feb 02, 2026, at 12:45 Indian Standard Time to review unaudited consolidated and standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).
Actualización del análisis • Feb 04

512070: Higher Margin Assumptions And Upcoming Results Will Support A Stronger Fair Value Outlook

Analysts have raised their fair value estimate for UPL from ₹944 to ₹975, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News UPL has scheduled a board meeting on Feb 02, 2026, at 12:45 Indian Standard Time to review unaudited consolidated and standalone financial results.
Actualización del análisis • Jan 21

512070: Higher Revenue And Margin Assumptions Will Support A Stronger Fair Value Outlook

Analysts have raised their fair value estimate for UPL from ₹911.93 to ₹944.00 after updating their assumptions for revenue growth, profit margins, discount rate and future P/E. What's in the News UPL has scheduled a Board Meeting on November 6, 2025 to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the Limited Review Reports from the statutory auditors (company filing).
Actualización del análisis • Jan 07

512070: Small Assumption Tweaks Will Likely Fail To Prevent Margin Pressure

Analysts have slightly increased their fair value estimate for UPL from ₹596.98 to ₹600.67. This reflects small adjustments to assumptions around the discount rate, revenue growth, profit margins and future P/E multiples.
Actualización del análisis • Dec 19

512070: Future Margins Will Likely Deteriorate Despite Higher Market Expectations

Analysts have raised their price target for UPL from approximately 526.51 to 596.98, citing slightly stronger expectations for revenue growth and future valuation multiples, partly offset by a more conservative view on profit margins and discount rates. What's in the News UPL Limited has scheduled a board meeting for November 06, 2025 to consider and approve unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the limited review reports from the statutory auditors (company filing).
Actualización del análisis • Dec 05

512070: Board Meeting And Stable Assumptions Will Shape Medium Term Outlook

Analysts have modestly raised their price target for UPL to ₹781.39, reflecting slightly improved discount rate and future P E assumptions, while largely maintaining their views on growth and profitability. What's in the News A board meeting is scheduled on November 6, 2025 to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the Statutory Auditors' limited review reports (company filing).
Actualización del análisis • Nov 21

512070: Board Meetings And Adjusted Forecasts Will Influence Medium-Term Outlook

Analysts have raised their price target for UPL from $756.34 to $781.39. This reflects optimism driven by slightly improved revenue growth expectations and adjustments to projected profit margins and valuation multiples.
Actualización del análisis • Nov 07

512070: Upcoming Board Decisions And Steady Financials Will Shape Outlook

Analysts have raised their price target for UPL from $736.09 to $756.34. They cite modest improvements in profit margin and revenue growth forecasts as the reason for this adjustment.
User avatar
Nuevo análisis • Dec 10

Biosolutions Innovation And Improved Financial Stability Expected To Boost Earnings Growth

Strategic inventory management and sales mix enhancement are expected to boost margins and improve earnings.

Previsiones de crecimiento de beneficios e ingresos

BSE:512070 - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
3/31/2028583,25545,94470,414N/A15
3/31/2027539,75636,48165,672N/A18
3/31/2026499,38323,57039,971N/A18
12/31/2025490,77016,210N/AN/AN/A
9/30/2025477,15020,53060,52077,890N/A
6/30/2025467,86010,570N/AN/AN/A
3/31/2025466,3707,61083,790100,740N/A
12/31/2024451,420-950N/AN/AN/A
9/30/2024441,220-21,40069,33087,980N/A
6/30/2024432,020-18,860N/AN/AN/A
3/31/2024430,980-13,360-1,73018,220N/A
12/31/2023455,890-5,830N/AN/AN/A
9/30/2023493,81017,2103,88026,540N/A
6/30/2023517,18027,240N/AN/AN/A
3/31/2023535,76034,35053,91077,510N/A
12/31/2022528,68040,360N/AN/AN/A
9/30/2022504,86038,85014,92043,170N/A
6/30/2022485,46037,050N/AN/AN/A
3/31/2022462,40035,05038,08064,960N/A
12/31/2021431,75032,200N/AN/AN/A
9/30/2021410,04030,78024,52046,600N/A
6/30/2021393,76029,070N/AN/AN/A
3/31/2021386,94027,81050,90072,120N/A
12/31/2020370,39024,250N/AN/AN/A
9/30/2020368,05023,39053,29073,610N/A
6/30/2020356,83020,420N/AN/AN/A
3/31/2020357,56017,76067,59087,390N/A
12/31/2019331,40013,650N/AN/AN/A
9/30/2019291,6909,340N/A40,010N/A
6/30/2019256,09011,150N/AN/AN/A
3/31/2019218,37014,910N/A23,560N/A
12/31/2018190,03019,770N/AN/AN/A
9/30/2018182,76020,900N/AN/AN/A
6/30/2018177,89020,590N/AN/AN/A
3/31/2018173,78020,220N/A28,360N/A
12/31/2017170,29020,270N/AN/AN/A
9/30/2017167,54019,120N/AN/AN/A
6/30/2017165,25018,400N/AN/AN/A
3/31/2017163,12017,270N/A25,850N/A
12/31/2016146,18015,473N/AN/AN/A
9/30/2016140,16313,692N/AN/AN/A
6/30/2016135,36613,840N/AN/AN/A
3/31/2016140,4809,400N/A13,960N/A
12/31/2015125,86111,913N/AN/AN/A
9/30/2015125,37011,538N/AN/AN/A
6/30/2015123,97811,347N/AN/AN/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (42% al año) de 512070 es superior a la tasa de ahorro (6.9%).

Beneficios vs. Mercado: Se prevé que los beneficios (42% al año) de 512070 crezcan más rápidamente que el mercado Indian (16.8% al año).

Beneficios de alto crecimiento: Se espera que los beneficios de 512070 crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (7.8% al año) de 512070 crezcan más despacio que el mercado de Indian (11% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 7.8% al año) de 512070 crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de 512070 sea baja dentro de 3 años (11.6%).

Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/05/09 10:06
Precio de las acciones al final del día2026/05/08 00:00
Beneficios2025/12/31
Ingresos anuales2025/03/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

UPL Limited está cubierta por 46 analistas. 18 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
null null360 ONE Capital Market Private Limited
null nullAnand Rathi Shares and Stock Brokers Limited
Himanshu BinaniAnand Rathi Shares and Stock Brokers Limited